Cho MS, Kang DY, Lee JB, Oh YS, et al. Off-label underdosing of edoxaban antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease: findings from the EPIC-CAD trial. Heart 2025 Sep 9:heartjnl-2025-326646. doi: 10.1136/heartjnl-2025-326646.
PMID: 40930594